Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs112080769 | chr16:71816369 | A/AATT | 0.000184 | 108 | 16.17 | 11.1 | 0 | KM Plot |
LAML | rs11210748 | chr1:43360120 | C/T | 0.00018 | 110 | 16.3 | 11.13 | 1.02 | KM Plot |
LAML | rs11223631 | chr11:133810195 | G/A | 1.83E-9 | 110 | 13.1 | 17.82 | 0.52 | KM Plot |
LAML | rs11223639 | chr11:133819442 | A/G | 5.8E-5 | 111 | 13.1 | 23.37 | 1.03 | KM Plot |
LAML | rs11229549 | chr11:58395914 | T/C | 1.98E-5 | 110 | 20.27 | 11.13 | 4.58 | KM Plot |
LAML | rs112316871 | chr13:100088157 | CT/C | 5.58E-5 | 111 | 17.23 | 10.67 | 1.02 | KM Plot |
LAML | rs112349545 | chr1:43337978 | T/C | 0.000166 | 110 | 15.73 | 10.67 | 1.02 | KM Plot |
LAML | rs112396958 | chr6:134284610 | T/C | 0.000172 | 109 | 16.17 | 10.13 | 1 | KM Plot |
LAML | rs11253451 | chr10:852885 | C/T | 2.75E-6 | 109 | 16.3 | 16.17 | 7.13 | KM Plot |
LAML | rs11253504 | chr10:956046 | A/G | 4.43E-5 | 110 | 15.23 | 14.63 | 5.1 | KM Plot |
LAML | rs11253518 | chr10:971600 | A/C | 6.36E-5 | 111 | 15.23 | 16.17 | 5.1 | KM Plot |
LAML | rs112588913 | chr13:21844277 | C/T | 1.06E-8 | 109 | 16.2 | 13.1 | 0 | KM Plot |
LAML | rs112694468 | chr20:48619336 | C/T | 0.000148 | 111 | 12.65 | 22.28 | 0 | KM Plot |
LAML | rs112740904 | chr13:114631075 | T/G | 5.45E-7 | 110 | 12.65 | 19.82 | 0.5 | KM Plot |
LAML | rs112751657 | chr6:127630589 | TAAAGAA/T | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |